4201. Improving Patient Outcomes With Rapid Optimization of GDMT For Heart Failure: Insights From the STRONG-HF Trial
Sponsored by Roche Diagnostics Corporation

Join Dr. Greene for a review of the rationale and supporting evidence for simultaneous or rapid sequence initiation and titration of GDMT for heart failure. The discussion will include a deep dive into the STRONG-HF trial supporting the safety and efficacy of this approach, and the role of NT-proBNP in medication titration.

Speaker:
Stephen J. Greene, MD, FACC, FHFSA
Division of Cardiology, Duke Clinical Research Institute and Duke University School of Medicine
Durham, NC, USA

4202. Clinical Insights in PAD: Reducing the Risk of Major Thrombotic Vascular Events
Sponsored by Janssen Pharmaceuticals, Inc.

This lecture will discuss reduction of the risk of major thrombotic vascular events (myocardial infarction, ischemic stroke, acute limb ischemia, and major amputation of a vascular etiology) in adult patients with peripheral artery disease (PAD), including patients after lower extremity revascularization due to symptomatic PAD.

Speaker:
Javier A. Valle, MD, MSCS, FACC, FSCAI
Interventional Cardiologist
Assistant Professor, University of Colorado
Michigan Heart and Vascular
Ann Arbor, MI

4203. Pulmonary Arterial Hypertension (PAH): Overview, Pathophysiology and Clinical Considerations
Sponsored by Merck

The learning objectives for this session include:

1. Review PAH, a rare, complex disease that carries a poor prognosis
2. Understand the multifaceted nature of disease progression and its impact on the heart and lungs
3. Recognize the importance of risk assessment and regular, collaborative care for patients with PAH

Speaker:
Anjali Vaidya, MD
Professor of Medicine, Co-Director of the Pulmonary Hypertension, Right Heart Failure & CTEPH Program, and Director of the Pulmonary Hypertension Fellowship Program at Temple University Lewis Kratz School of Medicine in Philadelphia, PA

4204. CCM® Therapy: Your Patients Want to Feel Better!
Sponsored by Impulse Dynamics

This session will explain what cardiac contractility modulation therapy is, how it works, and expected outcomes. The faculty will share their personal experiences and what they have learned about CCM®, how they have increased awareness in their practice communities, and how to identify appropriate candidates for this important new device therapy for heart failure in patients who have had limited options until now.

Speakers:
Joyce Wald, DO
Philadelphia, PA

Niraj Varma, MD
Cleveland, OH

Andrew Kaplan, MD, FACC
Mesa, AZ

4205. Detailed Imaging in Alphenix Adds An Additional Level Of Confidence, Enabling You To Prioritize Outcomes and Patient Safety
Sponsored by Canon Medical Systems USA, Inc

Join us at the Innovation Stage and gain exclusive insights into the implementation of a Alphenix and hybrid Angio-CT systems in lnterventional Cardiology that help you to confidently diagnose, analyze and treat challenging patients. Dr. Stephen Ramee shares his first experiences using the new Alphenix system to successfully treat and manage complex interventional cardiology procedures. Utilizing intraprocedural CT in an Angio-CT suite to image a left atrial appendage closure (LAA) device prior to device release, Dr. Brian Schuler demonstrates how he successfully predicted and prevented a potential LAAO closure leak with verified follow up of perfect device deployment and successful outcomes.

Speakers:
Stephen Rame, MD, FACC
Medical Director, Structural and Valvular Heart Center, Ochsner Health, New Orleans, LA

Brian Schuler, MD
Medical Director, WellSpan Health, York, PA

4206. Clinical Insights in NVAF: Reducing the Risk of Stroke and Systemic Embolism
Sponsored by Janssen Pharmaceuticals, Inc.

Patients with nonvalvular atrial fibrillation (NVAF) are at risk of stroke. This lecture will present an option for reducing the risk of stroke in NVAF patients, including those with obesity.

Speaker:
Marc Cohen, MD, FACC
Chairman, Department of Medicine
Formerly, Director, Division of Cardiology
Newark Beth Israel Medical Center
Professor of Medicine
Rutgers New Jersey Medical School
Newark, New Jersey

4207. Operationalizing CCM® Therapy
Sponsored by Impulse Dynamics

This session will explain what cardiac contractility modulation therapy is, how it works, and expected outcomes. The faculty will share their personal experiences and what they have learned about CCM®, how they have increased awareness in their practice communities, and how to identify appropriate candidates for this important new device therapy for heart failure in patients who have had limited options until now.

Speakers:
Suneet Mittal, MD
Ridgewood, NJ

Ashish Gupta, MD
Phoenix, AZ

Sonja Brune, NP
San Antonio, TX

4208. Eliminating the "mis" in Diagnosis of AS and Evidence Updates in Optimizing TAVR Outcomes
Sponsored by Medtronic

Discuss current challenges in the diagnosis of severe AS and latest updates in TAVR for optimizing outcomes.

Speakers:
Wayne Batchelor, MD, FACC, FSCAI
Director of Interventional Cardiology
Director of International Cardiology Research and Innovation
Associate Director, Inova Heart and Vascular Institute

Renuka Jain, MD, FACC, FASE
Director of Structural and Interventional Echocardiography
Aurora Health Care

Martha Gulati, MD MS, FACC, FAHA, FASPC, FESC
Director of Prevention & Associate Director of the Barbra Streisand Women's Heart Center
Cedars-Sinai Heart Institute

4209. Innovative Alphenix High Definition (HD 76) Imaging System For Complex Interventional Cardiology Procedures
Sponsored by Canon Medical Systems USA, Inc

Learn how seamlessly integrating the world's first High Definition (HD 76) imaging technology into the Alphenix family brings a new level of clarity to complex, intricate vasculature and device details. Using this novel HD 76 imaging system, Dr. Salman Arain shows that HD 76 can be safely used to improve visualization of coronary and peripheral arteries, and interventional devices during PCI in real-time with no observable increase in patient dose. Dr. Barry Bertolet will also discuss how the HD 76 technology helps to deliver safer patient care in interventional cases.

Speakers:
Salman Arain, MD, FACC
Associate Professor, UTHealth Houston
Houston, TX

Barry Bertolet, MD, FACC
Director of Cardiac Catheterization Laboratory, North Mississippi Health Services
Tupelo, MS

4210. 4D ICE Expert Position For Structural Heart Disease Interventions
Sponsored by Siemens Healthineers

Introduction to the 4D ICE Expert Position for Structural Heart Disease Interventions

Speakers:
Jagat Narula, PhD, MD, MACC (Moderator)
UTHealth Houston, McGovern Medical School
Houston, Texas, USA

Sergio Berti, MD
Cardiology Unit, Fondazione Toscana Gabriele Monasterio
Massa, Italy

Chad Kliger, MD
Department of Cardiovascular & Thoracic Surgery
Lenox Hill Hospital, Northwell Health, USA

Vaikom Mahadevan, MD
University of Massachusetts
Chan School of Medicine, USA

Alok Sharma, MD
Minneapolis Veterans Affairs Medical Center
University of Minnesota
Minneapolis, Minnesota, USA

Mani A Vannan, MD
Marcus Heart Valve Center, Piedmont Heart Institute
Atlanta, Georgia, USA

4211. AI in Action: Transforming the Cardiology Workflow
Sponsored by Viz.ai

Join this session as Dr. Suneet Mittal, Valley Health System & Dr. Jonathan Hsu, University of California, San Diego present their real world experience with AI to seamlessly direct patients to the right specialist, addressing loss to follow up and delayed disease detection in the case of cryptogenic stroke and hypertrophic cardiomyopathy (HCM).

Speakers:
Suneet Mittal, MD
Director of Electrophysiology, Valley Medical Group, Valley Health System

Jonathan Hsu, MD, MAS
Cardiac Electrophysiologist and Professor of Medicine at University
California, San Diego